News
GLP-1 meds may help — or harm — those with bipolar disorder. Read firsthand accounts of mood changes, weight loss, and side ...
A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.
A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...
While Americans understand the benefits of GLP-1 agonist medications, 83% of Americans are unwilling to pay more than $100 in ...
By triggering weight loss using the likes of Ozempic, people can expect various possible changes to their appearance ...
11h
Stocktwits on MSNMetsera Stock Climbs On Positive Results From Early Stage Trial For Investigational Weight-Loss Drug: Retail Chatter ExplodesShares of Metsera, Inc. (MTSR) soared 12% on Monday after the company announced positive topline data from an early-stage ...
David Kessler, former FDA commissioner, discusses the use of GLP-1 weight loss drugs, ‘toxic fat’ and the importance of one’s relationship with food on ‘Fox & Friends Weekend’.
Jack Daniel's is losing ground as Americans turn to cannabis, weight-loss drugs, and Gen Z snubs liquor. Discover why whiskey ...
New guidelines from the Society for Perioperative Assessment and Quality Improvement advise patients using GLP-1 medications for weight loss to fast for a longer period of time preoperatively, ...
Early-stage study results suggest that a single shot of the company’s therapy, which works differently than GLP-1 medicines, ...
Unlike injectable weight loss drugs that often serve as a temporary fix, Elcella seeks to naturally activate the gut’s own ...
Shares of weight-loss drug developer Metsera gained as much as 25% on Monday after the company's experimental drug helped patients lose weight in a small, early-stage trial, showing potential for a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results